NARA Discovery
Article Details
← Back to Search Results
Journal Article

Paclitaxel-loaded elastic liposomes synthesised by microfluidics technique for enhance transdermal delivery

Eman Jaradat; Adam Meziane; Dimitrios A. Lamprou
Drug Delivery and Translational Research · Vol. 15, Issue 4 · pp. 1265-1283 · 2025

Abstract

The inherent flexibility of elastic liposomes (EL) allows them to penetrate the small skin pores and reach the dermal region, making them an optimum candidate for topical drug delivery. Loading chemotherapy in ELs could improve chemotherapy’s topical delivery and localise its effect on skin carcinogenic tissues. Chemotherapy-loaded EL can overcome the limitations of conventional administration of chemotherapies and control the distribution to specific areas of the skin. In the current studies, Paclitaxel was utilised to develop Paclitaxel-loaded EL. As an alternative to the conventional manufacturing methods of EL, this study is one of the novel investigations utilising microfluidic systems to examine the potential to enhance and optimise the quality of Els by the microfluidics method. The primary aim was to achieve EL with a size of < 200 nm, high homogeneity, high encapsulation efficiency, and good stability. A phospholipid (DOPC) combined with neutral and anionic edge activators (Tween 80 and sodium taurocholate hydrate) at various lipid-to-edge activator ratios, was used for the manufacturing of the ELs. A preliminary study was performed to study the size, polydispersity (PDI), and stability to determine the optimum microfluidic parameters and lipid-to-edge activator for paclitaxel encapsulation. Furthermore, physiochemical characterisation was performed on the optimised Paclitaxel–loaded EL using a variety of methods, including Dynamic Light Scattering, Fourier Transform Infrared Spectroscopy, Atomic force microscopy, elasticity, encapsulation efficiency, and In vitro release. The results reveal the microfluidics’ significant impact in enhancing the EL characteristics of EL, especially small and controllable size, Low PDI, and high encapsulation efficiency. Moreover, the edge activator type and concentration highly affect the EL characteristics. The Tween 80 formulations with optimised concentration provide the most suitable size and higher encapsulation efficiency. The release profile of the formulations showed more immediate release from the EL with higher edge activator concentration and a higher % of the released dug from the Tween 80 formulations. Graphical Abstract

Bibliographic Information

JournalDrug Delivery and Translational Research
PublisherSpringer
Publication Date2025-04-01
Publication Year2025
Volume15
Issue4
Pages1265-1283
Document TypeJournal Article
Print ISSN2190-393X
eISSN2190-3948
DOI10.1007/s13346-024-01672-0

Access Information

NARA Access Coverage2011-01-01~Current
Journal Homepagehttps://www.springer.com/journal/13346
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.